Last 12 months
Inside the activity.
18 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 8 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 7 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Sep 30, 2026 14:25 UTC |
Catelani MichaelPresident, COO, & CFO
|
PurchaseCommon Stock | 5,500 | $2.84 | $15,620.00 |
DisclosureSEC source: 0001493152-26-045053 · ownership.xml · nonDerivative · entry 1 Catelani Michael · CIK 0001689394 · President, COO, & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| September 24, 2026 Filed Sep 28, 2026 12:45 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 7,000 | $2.78 | $19,460.00 |
DisclosureSEC source: 0001493152-26-044458 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 672,000 Read SEC document |
| September 24, 2026 Filed Sep 28, 2026 12:30 UTC |
Baskies Arnold MDirector
|
PurchaseCommon Stock | 5,000 | $2.76 | $13,800.00 |
DisclosureSEC source: 0001493152-26-044457 · ownership.xml · nonDerivative · entry 1 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,572 Read SEC document |
| September 23, 2026 Filed Sep 25, 2026 12:39 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 49,036 | $2.69 | $131,906.84 |
DisclosureSEC source: 0001493152-26-044250 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046,003 Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 13:45 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,000 | $2.75 | $8,250.00 |
DisclosureSEC source: 0001493152-26-042512 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 665,000 Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 13:15 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 10,000 | $2.73 | $27,300.00 |
DisclosureSEC source: 0001493152-26-042502 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 996,967 Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 12:00 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $2.76 | $13,800.00 |
DisclosureSEC source: 0001493152-26-042302 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 662,000 Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 08:45 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $3.47 | $17,350.00 |
DisclosureSEC source: 0001493152-26-035751 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 657,000 Read SEC document |
| July 27, 2026 Filed Jul 27, 2026 15:25 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,188 | $3.37 | $10,743.56 |
DisclosureSEC source: 0001493152-26-034772 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 647,000 Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 10:20 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $3.44 | $17,200.00 |
DisclosureSEC source: 0001493152-26-034952 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 652,000 Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 09:14 UTC |
Baskies Arnold MDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001493152-26-035122 · ownership.xml · derivative · entry 3 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2026-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right-To-Buy, pursuant to a stock option grant dated August 23, 2013. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 09:14 UTC |
Baskies Arnold MDirector
|
Tax withholdingCommon Stock | 5,428 | $3.46 | $18,780.88 |
DisclosureSEC source: 0001493152-26-035122 · ownership.xml · nonDerivative · entry 2 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,572 F1 · kind: The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 09:14 UTC |
Baskies Arnold MDirector
|
Exercise / conversionCommon Stock | 6,000 | $3.13 | $18,780.00 |
DisclosureSEC source: 0001493152-26-035122 · ownership.xml · nonDerivative · entry 1 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2026 Filed Jul 27, 2026 09:00 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,000 | $3.73 | $11,190.00 |
DisclosureSEC source: 0001493152-26-034723 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 643,812 Read SEC document |
| July 20, 2026 Filed Jul 20, 2026 18:19 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 12,000 | $3.47 | $41,640.00 |
DisclosureSEC source: 0001493152-26-033949 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 986,967 Read SEC document |
| July 20, 2026 Filed Jul 21, 2026 10:23 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $3.46 | $17,300.00 |
DisclosureSEC source: 0001493152-26-034027 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 640,812 Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 09:00 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 2,797 | $3.28 | $9,174.16 |
DisclosureSEC source: 0001493152-26-033461 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 974,967 Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 08:59 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $3.04 | $15,200.00 |
DisclosureSEC source: 0001493152-26-032961 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 635,812 Read SEC document |
| June 16, 2026 Filed Jun 17, 2026 11:21 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 2,836 | $2.64 | $7,487.04 |
DisclosureSEC source: 0001493152-26-029030 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 972,170 Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 09:00 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
PurchaseCommon Stock | 21,000 | $2.50 | $52,500.00 |
DisclosureSEC source: 0001493152-26-028827 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,812 Read SEC document |
| January 28, 2026 Filed Jan 29, 2026 08:58 UTC |
Baskies Arnold MDirector
|
PurchaseCommon Stock | 10,000 | $3.04 | $30,400.00 |
DisclosureSEC source: 0001493152-26-004148 · ownership.xml · nonDerivative · entry 1 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 19:44 UTC |
Titterton Lewis H jrDirector
|
GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001493152-26-000689 · ownership.xml · derivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-01-05 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 19:42 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
GrantEmployee Stock Option · Derivative | 350,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001493152-26-000688 · ownership.xml · derivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2036-01-05 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 19:41 UTC |
Gottschalk EmilyDirector
|
GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001493152-26-000687 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-01-05 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 19:41 UTC |
Catelani MichaelPresident, COO & CFO
|
GrantEmployee Stock Option · Derivative | 175,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001493152-26-000686 · ownership.xml · derivative · entry 1 Catelani Michael · CIK 0001689394 · President, COO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2036-01-05 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 19:40 UTC |
Baskies Arnold MDirector
|
GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001493152-26-000685 · ownership.xml · derivative · entry 1 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2036-01-05 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 08:56 UTC |
Titterton Lewis H jrDirector
|
Exercise / conversionEmployee Stock Option · Derivative | 16,000 | $0.00 Strike: $2.92 | $0.00 |
DisclosureSEC source: 0001493152-25-027904 · ownership.xml · derivative · entry 2 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Right-To-Buy, pursuant to a stock option grant dated February 18, 2016. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 08:56 UTC |
Titterton Lewis H jrDirector
|
Exercise / conversionCommon Stock | 16,000 | $2.92 | $46,720.00 |
DisclosureSEC source: 0001493152-25-027904 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 969,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2025 Filed Oct 31, 2025 09:13 UTC |
KUMAR AMITChief Executive Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.92 | $0.00 |
DisclosureSEC source: 0001493152-25-020322 · ownership.xml · derivative · entry 3 KUMAR AMIT · CIK 0001191905 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Right-To-Buy, pursuant to a stock option grant dated February 18, 2016. F3 · derivative.exercise_date: The option vested in 36 consecutive monthly installments beginning on March 31, 2016. Read SEC document |
| October 30, 2025 Filed Oct 31, 2025 09:13 UTC |
KUMAR AMITChief Executive Officer
|
Tax withholdingCommon Stock | 169,439 | $4.06 | $687,922.34 |
DisclosureSEC source: 0001493152-25-020322 · ownership.xml · nonDerivative · entry 2 KUMAR AMIT · CIK 0001191905 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,486 F1 · kind: The reporting person exercised the stock options at this time due to their upcoming expiration on February 18, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options. Read SEC document |
| October 30, 2025 Filed Oct 31, 2025 09:13 UTC |
KUMAR AMITChief Executive Officer
|
Exercise / conversionCommon Stock | 200,000 | $2.92 | $584,000.00 |
DisclosureSEC source: 0001493152-25-020322 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 779,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2025 Filed Aug 4, 2025 09:00 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 10,000 | $3.08 | $30,800.00 |
DisclosureSEC source: 0001641172-25-022000 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 953,334 Read SEC document |
| July 30, 2025 Filed Jul 31, 2025 09:00 UTC |
KUMAR AMITChief Executive Officer
|
PurchaseCommon Stock | 5,000 | $3.16 | $15,800.00 |
DisclosureSEC source: 0001641172-25-021679 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 579,925 Read SEC document |
| July 18, 2025 Filed Jul 21, 2025 08:30 UTC |
Baskies Arnold MDirector
|
PurchaseCommon Stock | 5,000 | $3.39 | $16,950.00 |
DisclosureSEC source: 0001641172-25-020362 · ownership.xml · nonDerivative · entry 1 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Read SEC document |
| July 11, 2025 Filed Jul 14, 2025 08:40 UTC |
KUMAR AMITChief Executive Officer
|
PurchaseCommon Stock | 5,000 | $3.15 | $15,750.00 |
DisclosureSEC source: 0001641172-25-018898 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,925 Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 06:03 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 10,000 | $3.14 | $31,400.00 |
DisclosureSEC source: 0001641172-25-019587 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 943,334 Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 09:11 UTC |
KUMAR AMITChief Executive Officer
|
PurchaseCommon Stock | 10,000 | $2.85 | $28,500.00 |
DisclosureSEC source: 0001641172-25-013724 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,925 Read SEC document |
| January 28, 2025 Filed Jan 29, 2025 10:06 UTC |
Baskies Arnold MDirector
|
PurchaseCommon Stock | 5,000 | $2.82 | $14,100.00 |
DisclosureSEC source: 0001493152-25-004108 · ownership.xml · nonDerivative · entry 1 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 09:14 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 1,000 | $3.00 | $3,000.00 |
DisclosureSEC source: 0001493152-25-003733 · ownership.xml · nonDerivative · entry 2 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 933,334 Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 09:14 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 2,000 | $2.91 | $5,820.00 |
DisclosureSEC source: 0001493152-25-003733 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 932,334 Read SEC document |
| January 22, 2025 Filed Jan 23, 2025 09:11 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 2,000 | $3.01 | $6,020.00 |
DisclosureSEC source: 0001493152-25-003330 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,334 Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 09:13 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 6,000 | $2.59 | $15,540.00 |
DisclosureSEC source: 0001493152-25-003157 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 928,334 Read SEC document |
| January 17, 2025 Filed Jan 17, 2025 14:05 UTC |
Titterton Lewis H jrDirector
|
PurchaseCommon Stock | 10,000 | $2.57 | $25,700.00 |
DisclosureSEC source: 0001493152-25-002717 · ownership.xml · nonDerivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 922,334 Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 13:15 UTC |
KUMAR AMITChief Executive Officer
|
PurchaseCommon Stock | 43,000 | $2.23 | $95,890.00 |
DisclosureSEC source: 0001493152-25-002321 · ownership.xml · nonDerivative · entry 1 KUMAR AMIT · CIK 0001191905 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559,925 Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 12:48 UTC |
Catelani MichaelPresident, COO, & CFO
|
PurchaseCommon Stock | 9,289 | $2.15 | $19,971.35 |
DisclosureSEC source: 0001493152-25-002314 · ownership.xml · nonDerivative · entry 1 Catelani Michael · CIK 0001689394 · President, COO, & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 17:40 UTC |
Titterton Lewis H jrDirector
|
GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-25-000317 · ownership.xml · derivative · entry 1 Titterton Lewis H jr · CIK 0001499254 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-01-02 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 17:40 UTC |
KUMAR AMITDirector · Chief Executive Officer
|
GrantEmployee Stock Option · Derivative | 700,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-25-000316 · ownership.xml · derivative · entry 1 KUMAR AMIT · CIK 0001191905 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2035-01-02 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 17:40 UTC |
Gottschalk EmilyDirector
|
GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-25-000315 · ownership.xml · derivative · entry 1 Gottschalk Emily · CIK 0001791108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-01-02 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 17:40 UTC |
Baskies Arnold MDirector
|
GrantEmployee Stock Option · Derivative | 25,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-25-000313 · ownership.xml · derivative · entry 1 Baskies Arnold M · CIK 0001683567 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-01-02 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 17:40 UTC |
Catelani MichaelPresident, COO & CFO
|
GrantEmployee Stock Option · Derivative | 350,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001493152-25-000314 · ownership.xml · derivative · entry 1 Catelani Michael · CIK 0001689394 · President, COO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2035-01-02 F1 · security: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. F2 · derivative.exercise_date: The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.